首页> 外国专利> tamper resistant agonist opioid formulas, method for reducing abuse of an agonist opioid in an oral dosage formula, method of preparing an oral dosage formula and method of treating pain

tamper resistant agonist opioid formulas, method for reducing abuse of an agonist opioid in an oral dosage formula, method of preparing an oral dosage formula and method of treating pain

机译:防篡改激动剂阿片类药物制剂,减少口服制剂中激动剂阿片类药物滥用的方法,制备口服制剂的方法和治疗疼痛的方法

摘要

"Tamper Resistant Agonist Opioid Formulas, Method for Reducing Abuse of an Agonist Opioid in an Oral Dosage Formula, Method of Preparation of an Oral Dosage Formula, and Pain Treatment Method". said oral dosage formula comprising (i) a releasable agonist opioid and (ii) a sequestered antagonist opioid which is substantially unreleased when the dosage formula is administered intact such that the proportion of the amount of said released antagonist of said formula after adulteration for the amount of said agonist released from said intact dosage formula is about 4: 1 or greater, based on 1 hour in vitro dissolution of said dosage formula in 900 ml simulated gastric fluid using a type ii (paddle) apparatus at 75rpm and 37Â ° C, characterized in that said agonist and antagonist are interdispersed and are not isolated from one another in two distinct layers. the method for decreasing abuse of an opioid containing incorporation of said agonist opioid into a dosage form defined above. the method of preparation comprising pretreatment of an antagonist opioid to make it substantially non-releasable; and combining the pretreated antagonist with a releasable form of an agonist opioid. the method of treating pain comprising administering to a human patient a dosage form defined above.
机译:“防篡改激动剂阿片类药物配方,减少口服制剂中滥用激动剂阿片类药物的方法,口服制剂的制备方法和疼痛治疗方法”。所述口服剂型包含(i)可释放的激动剂阿片样物质和(ii)螯合的拮抗剂阿片样物质,当完整地施用该剂型时,基本上不释放,使得在掺假后所述配方的所述释放的拮抗剂的量的比例从所述完整剂量公式释放的所述激动剂的剂量约为4:1或更大,基于使用II型(桨式)装置在75rpm和37°C下将所述剂量公式在900 ml模拟胃液中体外溶解1小时的特征,其中所述激动剂和拮抗剂是相互分散的,并且没有在两个不同的层中彼此分离。减少阿片类药物滥用的方法,包括将所述激动剂阿片类药物掺入上文定义的剂型中。该制备方法包括对拮抗剂阿片样物质进行预处理以使其基本上不可释放。将预处理的拮抗剂与可释放形式的激动剂阿片样物质组合。该治疗疼痛的方法包括向人类患者施用上述定义的剂型。

著录项

  • 公开/公告号BRPI0108380A8

    专利类型

  • 公开/公告日2018-04-24

    原文格式PDF

  • 申请/专利权人 EURO-CELTIQUE S/A;

    申请/专利号BR2001PI08380

  • 发明设计人 BENJAMIN OSHLACK;CURTIS WRIGHT;

    申请日2001-02-08

  • 分类号A61K9/08;A61K31/485;A61K9;A61K9/02;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/26;A61K9/28;A61K9/48;A61K9/50;A61K9/52;A61K9/54;A61K9/58;A61K9/70;A61K31/135;A61K31/137;A61K31/451;A61K31/46;A61K38;A61K45/06;A61K45/08;A61K47/02;A61K47/14;A61K47/26;A61K47/32;A61K47/38;A61P25/04;A61P39;A61P43;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号